Quince Therapeutics Inc (QNCX)

Quince Therapeutics Inc Azioni (QNCX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	13.07% 11.22	9.921	6.094	5.584	12.96
Depreciation and Amortization	86.84% 0.04	0.304	-	0.001	0.017
Operating Income/Loss	13.07% -11.22	-9.921	-6.094	-5.584	-12.96
Income/Loss From Continuing Operations Before Tax	25.73% -11.12	-8.843	-5.351	-4.886	-12.50
Income Tax Expense/Benefit	93.03% 0.031	0.445	-	-	-0.248
Income/Loss From Continuing Operations After Tax	20.04% -11.15	-9.288	-5.351	-4.886	-12.25
Net Income/Loss	25.35% -11.15	-8.894	-5.351	-4.886	-12.25
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,219% 43.01	1.2959	36.07	35.92	35.86
Diluted Average Shares	3,219% 43.01	1.2959	36.07	35.92	35.86
Basic Earnings Per Share	23.81% -0.26	-0.21	-0.15	-0.14	-0.34
Diluted Earnings Per Share	23.81% -0.26	-0.21	-0.15	-0.14	-0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-